# CAR-T Therapy for Refractory Autoimmune Diseases

> **NCT07059169** · NA · RECRUITING · sponsor: **LiangZou** · enrollment: 20 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** JY231 (JY231 injection)

## Key facts

- **NCT ID:** NCT07059169
- **Lead sponsor:** LiangZou
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-04
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07059169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07059169, "CAR-T Therapy for Refractory Autoimmune Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07059169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*